{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:54Z","timestamp":1783416354595,"version":"3.54.6"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study investigates the role of carbohydrate antigen 125 (CA125) in the pathogenesis of systemic lupus erythematosus (SLE) and analyzes factors associated with its elevation. A total of 220 patients diagnosed with SLE at the Department of Rheumatology and Immunology of our institution between January 2021 and January 2025 were enrolled. Among them, 63 patients with positive CA125 were assigned to the observation group, and 157 with negative CA125 served as the control group. Demographic data, clinical manifestations, and laboratory parameters were collected. Univariate and binary logistic regression analyses were performed to identify factors associated with CA125 positivity and to evaluate correlations between CA125 levels and clinical indicators. Logistic regression revealed that hypoproteinemia (odds ratio [OR]\u2005=\u20053.796,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.034), serous cavity effusion (OR\u2005=\u20053.169,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.045), albumin (ALB; OR\u2005=\u20051.121,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.01), complement 3 (C3; OR\u2005=\u20051.568,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.048), 25-hydroxyvitamin D3 (25(OH)D3; OR\u2005=\u20051.267,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.013), SLE Disease Activity Index (SLEDAI; OR\u2005=\u20050.764,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.019), and interleukin-6 (IL-6; OR\u2005=\u20050.960,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.009) were associated with elevated CA125. Regression analysis showed that CA125 was negatively correlated with 25(OH)D3 and ALB, and positively correlated with SLEDAI and IL-6. Hypoproteinemia and serous cavity effusion were independent predictors of elevated CA125 in SLE patients. These findings suggest that CA125 may serve as a potential serological marker reflecting disease activity and systemic inflammation in SLE, offering supportive value for clinical assessment and management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048959","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:00:59Z","timestamp":1779469259000},"page":"e48959","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Study on the expression characteristics of CA125 in patients with SLE and its correlation with clinical indicators"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4884-8529","authenticated-orcid":false,"given":"Shasha","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Hengshui People\u2019s Hospital, Hengshui, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hengshui People\u2019s Hospital, Hengshui, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hengshui People\u2019s Hospital, Hengshui, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Hengshui People\u2019s Hospital, Hengshui, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imm.13103","article-title":"Infectious processes and systemic lupus erythematosus.","volume":"158","author":"Illescas-Montes","year":"2019","journal-title":"Immunology"},{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/diseases12090226","article-title":"Mitochondrial dysfunction in systemic lupus erythematosus: insights and therapeutic potential.","volume":"12","author":"Poznyak","year":"2024","journal-title":"Diseases"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/kead224","article-title":"Tumour-associated antigens in systemic lupus erythematosus: association with clinical manifestations and serological indicators.","volume":"63","author":"Zhong","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.2001.6575","article-title":"Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.","volume":"85","author":"Topalak","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R5-20260707","first-page":"587","article-title":"Tumour markers in rheumatoid arthritis-associated interstitial lung disease.","volume":"34","author":"Wang","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaut.2008.08.008","article-title":"Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.","volume":"31","author":"Szekanecz","year":"2008","journal-title":"J Autoimmun"},{"key":"R7-20260707","first-page":"1341","article-title":"Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.","volume":"18","author":"Miret","year":"1998","journal-title":"Anticancer Res"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.autrev.2018.01.007","article-title":"Performance of the 2012 systemic lupus international collaborating clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysis.","volume":"17","author":"Hartman","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R9-20260707","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000.","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma.","volume":"68","author":"Bast","year":"1981","journal-title":"J Clin Invest"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/carcin\/bgab010","article-title":"The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia.","volume":"42","author":"Giamougiannis","year":"2021","journal-title":"Carcinogenesis"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.exer.2007.12.008","article-title":"Focus on molecules: human mucin MUC16.","volume":"87","author":"Perez","year":"2008","journal-title":"Exp Eye Res"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.clinbiochem.2013.09.008","article-title":"Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.","volume":"46","author":"Huang","year":"2013","journal-title":"Clin Biochem"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/0961203318776109","article-title":"Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.","volume":"27","author":"Obri\u0219c\u0103","year":"2018","journal-title":"Lupus"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/COC.2009.n.008","article-title":"Is serum albumin an independent predictor of survival in ovarian cancer.","volume":"2","author":"Gupta","year":"2009","journal-title":"Clin Ovarian Cancer"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1007\/s11255-024-04105-6","article-title":"Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus.","volume":"56","author":"Feng","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/nu11030638","article-title":"The prognostic nutritional index and nutritional risk index are associated with disease activity in patients with systemic lupus erythematosus.","volume":"11","author":"Correa-Rodr\u00edguez","year":"2019","journal-title":"Nutrients"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0961203314530792","article-title":"Association between serum trace element concentrations and the disease activity of systemic lupus erythematosus.","volume":"23","author":"Sahebari","year":"2014","journal-title":"Lupus"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/0961203316682095","article-title":"Serum 25-OH vitamin D level in treatment-na\u00efve systemic lupus erythematosus patients: relation to disease activity, IL-23 and IL-17.","volume":"26","author":"Shahin","year":"2016","journal-title":"Lupus"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1099800420983596","article-title":"Vitamin D levels are associated with disease activity and damage accrual in systemic lupus erythematosus patients.","volume":"23","author":"Correa-Rodr\u00edguez","year":"2021","journal-title":"Biol Res Nurs"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/IMI.S40035","article-title":"Vitamin D deficiency in Egyptian systemic lupus erythematosus patients: how prevalent and does it impact disease activity.","volume":"11","author":"Abaza","year":"2016","journal-title":"Integr Med Insights"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"e0170323","DOI":"10.1371\/journal.pone.0170323","article-title":"25-Hydroxivitamin D serum concentration, not free and bioavailable Vitamin D, is associated with disease activity in systemic lupus erythematosus patients.","volume":"12","author":"Eloi","year":"2017","journal-title":"PLoS One"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00296-010-1442-1","article-title":"Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus.","volume":"31","author":"Kim","year":"2011","journal-title":"Rheumatol Int"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/ken121","article-title":"Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences.","volume":"47","author":"Ruiz-Irastorza","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R25-20260707","first-page":"e73646","article-title":"Mechanisms underlying gender influence on the clinical course and immunopathogenesis of systemic lupus erythematosus: an explorative review.","volume":"16","author":"Varaganti","year":"2024","journal-title":"Cureus"},{"key":"R26-20260707","first-page":"1390","article-title":"Value of combined detection of anti-nuclear antibody, anti-double-stranded DNA antibody and C3, C4 complements in the clinical diagnosis of systemic lupus erythematosus.","volume":"17","author":"Qu","year":"2019","journal-title":"Exp Ther Med"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1055\/a-1347-5655","article-title":"The complex relationship between C4b-binding protein, warfarin, and antiphospholipid antibodies.","volume":"121","author":"Grosso","year":"2021","journal-title":"Thromb Haemost"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.immuni.2024.05.025","article-title":"Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity.","volume":"57","author":"Xu","year":"2024","journal-title":"Immunity"},{"key":"R29-20260707","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/156652409787847263","article-title":"Cytokines in systemic lupus erythematosus.","volume":"9","author":"Louren\u00e7o","year":"2009","journal-title":"Curr Mol Med"},{"key":"R30-20260707","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10238-014-0315-4","article-title":"Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.","volume":"15","author":"Palafox-S\u00e1nchez","year":"2015","journal-title":"Clin Exp Med"},{"key":"R31-20260707","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacol Ther"},{"key":"R32-20260707","doi-asserted-by":"crossref","first-page":"300060520926882","DOI":"10.1177\/0300060520926882","article-title":"Cytokine clusters as potential diagnostic markers of disease activity and renal involvement in systemic lupus erythematosus.","volume":"48","author":"Park","year":"2020","journal-title":"J Int Med Res"},{"key":"R33-20260707","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/cts.13283","article-title":"Serum cytokines to predict systemic lupus erythematosus clinical and serological activity.","volume":"15","author":"Moreno-Torres","year":"2022","journal-title":"Clin Transl Sci"},{"key":"R34-20260707","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41419-020-03067-8","article-title":"ERO1L promotes IL6\/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells.","volume":"11","author":"Lei","year":"2020","journal-title":"Cell Death Dis"},{"key":"R35-20260707","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-019-5611-7","article-title":"Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.","volume":"19","author":"Matte","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:01:47Z","timestamp":1783414907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":35,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048959","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2026-01-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}